Cargando…

Routine Bone Imaging for Metastatic Renal Cell Carcinoma: Is it Time?

Detalles Bibliográficos
Autor principal:	Parikh, Mamta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Codon Publications 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523176/ https://www.ncbi.nlm.nih.gov/pubmed/34722127 http://dx.doi.org/10.15586/jkcvhl.v8i4.207

Ejemplares similares

Update on the treatment of metastatic renal cell carcinoma
por: Medina López, Rafael Antonio, et al.
Publicado: (2022)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
por: Bongartz, Georg
Publicado: (2007)

Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
por: Lin, Justin, et al.
Publicado: (2021)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Renal Cell Carcinoma with bone metastases isn’t always bad
por: Ruatta, Fiorella, et al.
Publicado: (2019)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
por: Yoshimura, Akihiro, et al.
Publicado: (2020)

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
por: Naito, Renato, et al.
Publicado: (2020)

Gene expression profiles and treatments for metastatic renal cell carcinoma: What does still need to be defined?
por: Giunta, Emilio F., et al.
Publicado: (2022)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
por: Iuliani, Michele, et al.
Publicado: (2021)

Is It the Right Time for Routine Clinical Application of Stem Cells in Reproductive Medicine?
por: Sadeghi, Mohammad Reza
Publicado: (2018)

Metastatic Renal Cell Carcinoma Presenting as Prolonged Pyrexia and Stauffer's Syndrome: Can a Routine Ultrasound Scan Fail to Detect a Renal Cell Carcinoma?
por: Fonseka, C. L., et al.
Publicado: (2018)

Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?
por: Wong, Emily C.L., et al.
Publicado: (2019)

Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
por: Di Napoli, Marilena, et al.
Publicado: (2022)

Corrigendum to “Metastatic Renal Cell Carcinoma Presenting as Prolonged Pyrexia and Stauffer's Syndrome: Can a Routine Ultrasound Scan Fail to Detect a Renal Cell Carcinoma?”
por: Fonseka, C. L., et al.
Publicado: (2018)

Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer?
por: Grinda, T., et al.
Publicado: (2023)

The Labyrinth of Renal Cell Carcinoma
por: Manini, Claudia, et al.
Publicado: (2020)

Real-Time Modeling Should Be Routinely Integrated into Outbreak Response
por: Bausch, Daniel G., et al.
Publicado: (2018)

New prognostic models in metastatic renal cancer
por: Lim, Louise, et al.
Publicado: (2012)

Imaging metastatic bone disease from carcinoma of the prostate
por: Messiou, C, et al.
Publicado: (2009)

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
por: Santoni, Matteo, et al.
Publicado: (2015)

Biology of Metastatic Renal Cell Carcinoma
por: Milella, Michele, et al.
Publicado: (2011)

Axitinib in Metastatic Renal Cell Carcinoma
por: Mittal, Kriti, et al.
Publicado: (2012)

Renal Cell Carcinoma Metastatic to the Scalp
por: Errami, Mounir, et al.
Publicado: (2016)

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
por: Teishima, Jun, et al.
Publicado: (2023)

High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features
por: Achkar, Tala, et al.
Publicado: (2017)

Stress imaging in patients with diabetes; routine practice?
por: van der Wall, E. E., et al.
Publicado: (2010)

Routine immunisation programmes in southeast Asia: beyond the routine
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?
por: Hardman, Morgan, et al.
Publicado: (2023)

Editorial Comment to A case of sarcoidosis‐like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Kijima, Toshiki
Publicado: (2021)

The time has come for next-generation sequencing in routine diagnostic workup in hematology
por: Haferlach, Torsten
Publicado: (2021)

Editorial Comment from Dr Kojima to Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
por: Kojima, Takahiro
Publicado: (2020)

Editorial Comment from Dr Yuasa to Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
por: Yuasa, Takeshi
Publicado: (2020)

Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study
por: Wang, Keyi, et al.
Publicado: (2021)

Immune checkpoint inhibitors in renal cell carcinoma
por: Ross, Kirsty, et al.
Publicado: (2017)

Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Capecitabine in the treatment of metastatic renal cell carcinoma
por: Oevermann, K, et al.
Publicado: (2000)

Targeted therapy for metastatic renal cell carcinoma
por: Patel, P H, et al.
Publicado: (2006)

Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rg6gcdbffagstpmniig171rhe6